-
November 10, 2026
Drugmaker Skye Bioscience Inc. has reached a $2.5 million settlement with investors that would end a proposed securities class action alleging the company overhyped a weight-loss drug, causing its stock price to plummet once the truth came to light.
-
November 10, 2026
The U.S. Tax Court improperly imposed additional accuracy-related penalties against a Florida business for deductions it took for microcaptive insurance expenses, the business' owner told the Eleventh Circuit, saying the Tax Court's analysis of the case can't be reconciled with binding circuit precedent.
-
November 10, 2026
A medical device company failed to provide Washington hourly workers with required meal and rest breaks, underpaid their wages and restricted their ability to discuss their pay, according to a proposed class action removed to Washington federal court.
-
November 10, 2026
Health intelligence platform Oura, advised by Latham & Watkins LLP, on Tuesday unveiled plans to acquire artificial intelligence-native primary care company Counsel Health in a $625 million deal.
-
November 10, 2026
The Pennsylvania state judge overseeing the city's Zantac mass tort litigation has again rejected claims that he might have a conflict of interest because his wife's firm represents a defendant in one of more than 500 such cases, pointing out that the case in question has been resolved.
-
November 10, 2026
A New Jersey bankruptcy judge on Tuesday denied the Office of the U.S. Trustee's bid to convert Invatech's bankruptcy to a Chapter 7 as the former generic pharmaceutical group works to wrap up an administratively insolvent Chapter 11.
-
November 10, 2026
A Massachusetts federal judge said Tuesday she will reduce an $88 million verdict awarded to an Alabama couple in the first bellwether hernia mesh trial against Medtronic subsidiary Covidien LP, saying the award appeared to be "the product of passion."
-
November 09, 2026
A Federal Circuit judge on Monday appeared perplexed by medical aesthetics provider Medytox Inc.'s position that the U.S. International Trade Commission wrongly rejected its claim that a rival stole its anti-wrinkle technology, saying Medytox's argument "has nothing to do" with the ruling.
-
November 09, 2026
The Ninth Circuit has set aside a judgment directing Research Development Foundation to pay royalties to Pacira Pharmaceuticals Inc. in a contract dispute involving the anesthetic Exparel, further remanding the case for a recalculation of prejudgment interest.
-
November 09, 2026
The attorney general of Ohio is seeking to amend its complaint accusing Express Scripts and several related entities of conspiring to raise prescription drug prices.
-
November 09, 2026
The U.S. Food and Drug Administration on Monday said it is requiring new warnings on GLP-1 medications, the group of blockbuster drugs prescribed for diabetes and weight loss, for a serious, rare condition that can cause sudden and possibly permanent vision loss in one eye.
-
November 09, 2026
Pharmaceutical company Compass Pathways announced Monday that it had submitted to the U.S. Food and Drug Administration a new drug application to treat treatment-resistant depression with psilocybin, the primary compound in psychoactive mushrooms.
-
November 09, 2026
Teva Pharmaceuticals has told a California federal court there is plenty of evidence for a jury to find that Corcept Therapeutics blocked generic competition for its cortisol disorder treatment Korlym by using an exclusive distribution deal with a specialty pharmacy.
-
November 09, 2026
Researchers on Monday challenged the impending phase-out of an office of the National Science Foundation that funds 64% of U.S. research in the social sciences, calling the move to eliminate funding illegal and devastating for their fields.
-
November 09, 2026
The Delaware Chancery Court last week cleared the way for Cloudflare Inc. to seek immediate review of an injunction blocking a stock restructuring designed to preserve its founders' control, while setting a January hearing in a similar dispute over Meta Platforms Inc.'s plan to create nonvoting shares.
-
November 09, 2026
The Seventh Circuit refused to reopen a suit alleging an Illinois county hospital fired a pharmacy technician for requesting a religious exemption from the COVID-19 vaccine, saying it was bound by a recent ruling nixing a similar case.
-
November 09, 2026
The U.S. Supreme Court on Monday declined to hear a real estate developer's case against the city of Pontiac, Michigan, alleging municipal officials violated constitutional rights by delaying approvals of a proposed cannabis operation until it was no longer viable.
-
November 09, 2026
The U.S. Supreme Court on Monday invited the U.S. solicitor general to opine on a lawsuit accusing pharmaceutical companies of aiding a Hezbollah-linked militia's terrorist activities in Iraq, after the D.C. Circuit held the plaintiffs adequately alleged that the companies' participation was conscious and voluntary.
-
November 09, 2026
The U.S. Supreme Court on Monday passed on reviewing a Second Circuit decision that refused to add some $66 million to a $16.6 million arbitral award issued to Acorda Therapeutics in a multiple sclerosis drug dispute, rejecting a petition that sought clarity on when an arbitrator "manifestly disregards" the law.
-
November 09, 2026
The U.S. Supreme Court on Monday declined to review a dispute over rights to healthcare software for a U.S. Army veterinary records system, after the Federal Circuit held a defense subcontractor failed to present a valid contract claim.
-
November 06, 2026
A Florida federal judge denied a bid by a German mosquito-bite patch maker to compel arbitration of a dispute over a license and distribution agreement for the products, ruling that the company's "halfhearted" conferral attempt with opposing counsel violated local rules.
-
November 06, 2026
A California federal court granted final approval to a $45 million settlement resolving proposed class action allegations that digital healthcare company iRhythm Technologies inflated stock prices with misrepresentations about its heart-event monitoring device.
-
November 06, 2026
GlaxoSmithKline and Moderna dismissed two Delaware federal patent suits Friday over Moderna's COVID-19 and respiratory syncytial virus vaccines, following a broader settlement in which the companies agreed to license patents to each other.
-
November 06, 2026
A Connecticut federal judge has granted final approval to a $29.6 million settlement between dozens of states and Glenmark Pharmaceuticals that resolves claims accusing the company of conspiring with competitors to drive up drug prices.
-
November 06, 2026
A Massachusetts jury said Friday that Johnson & Johnson owes $1.9 million for causing the mesothelioma, but not the death, of a former talcum powder user who also had a heart condition.